Rapport Therapeutics, Inc. (RAPP) KPIs and segments

RAPPNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30

$26.15+0.30 (+1.16%)

Close on Nov 13, 2026Market cap $1.25BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Rapport Therapeutics's business

Coming soon

This tab will track the numbers specific to Rapport Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?